Status:

UNKNOWN

Plaque Calcium Characterization and Ruptured Plaques

Lead Sponsor:

Li Min

Conditions:

Vulnerable Atherosclerotic Plaque

Eligibility:

All Genders

Brief Summary

Recently, ultrashort echo time (UTE) MR, which allows detection of the ultrashort T2 components, has been used to image plaque calcification in ex vivo carotid and coronary arteries. The results demon...

Detailed Description

Atherosclerosis, characterized by the accumulation of lipids and inflammatory cells in the large arteries, is one of the most common causes of morbidity and mortality in developed and developing count...

Eligibility Criteria

Inclusion

  • Patients referred for carotid endarterectomy or stent were prospectively enrolled.

Exclusion

  • Patients with ferromagnetic metal, active implants such as pacemakers, aneurysm clips, known claustrophobia, and those who were unable to provide informed consent were excluded from enrollment.

Key Trial Info

Start Date :

June 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03849521

Start Date

June 1 2019

End Date

December 31 2025

Last Update

February 21 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Min Li

Jinan, Shandong, China, 250031